15 December 2021>: Clinical Research
Risk Factors for Cryptococcal Meningitis Recurrence in Human Immunodeficiency Virus (HIV)-Infected Patients in a Large Chinese Acquired Immune Deficiency Syndrome (AIDS) Treatment Center
Yue Zhou 1AEF , Feng Li 1BCD , Rui Li 1BCD , Yuan Peng 1CD , Mei He 1CD , Fengjun Sun 2ADEF* , Ming Yang 12AEFG*DOI: 10.12659/MSM.933688
Med Sci Monit 2021; 27:e933688
Table 4 Antifungal drug susceptibility results (mg/L).
Antifungal agent | MIC90 | MIC50 |
---|---|---|
Amphotericin B | 2 | 0.25 |
Itraconazole | 0.5 | ≤0.125 |
Voriconazole | 1 | ≤0.125 |
Fluconazole | 8 | 2 |
5-fluorocytosine | 4 | 0.5 |
MIC – minimum inhibitory concentration. |